Form 4: Aquestive Therapeutics Insider Sells Shares

Melina Cioffi, SVP of Regulatory Affairs at Aquestive Therapeutics, reported a transaction involving the sale of 1,667 shares of common stock.

Summary

• Melina Cioffi, Senior Vice President of Regulatory Affairs at Aquestive Therapeutics, Inc., reported a transaction on May 15, 2026.
• The transaction involved the disposition of 1,667 shares of common stock.
• The shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of Restricted Stock Units (RSUs).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports a standard insider transaction for tax withholding purposes related to RSU vesting, which does not inherently signal positive or negative sentiment about the company's future performance.

Negatives

• Insider selling can sometimes be perceived negatively by the market, although in this case, it was for tax withholding purposes related to RSU vesting.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to an insider transaction.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The nature of this transaction, related to RSU vesting and tax withholding, is a common occurrence for executives and is generally not indicative of a negative view on the company's prospects by the insider.

Stakeholder Impact

• Shareholders: The transaction is a routine event for RSU vesting and tax settlement and is not expected to have a significant impact on the share price or overall shareholder value.

Key Dates

Keywords

Aquestive Therapeutics, SEC Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, RSU Vesting, Tax Withholding